The therapy targets CD19+ B cells, offering a new mechanism for managing this multiorgan fibroinflammatory disease.

The seven chimeric antigen receptor T-cell therapies approved in the United States have revolutionized treatment of blood cancers.Eight years after the first CAR-T product entered the market, members ...

Logan and Erin Dorsey, who fought sickle cell anemia for 11 years, are now nurses at the University of Mississippi Medical ...

Researchers found that zeaxanthin, long associated with eye health, may also boost the body’s immune response against cancer. In a recent study, scientists at the University of Chicago found that ...

Dr. Christina Cho, a hematologist/oncologist specializing in stem cell transplantation and cellular therapy at Hackensack Meridian Hackensack University Medical Center’s John Theurer Cancer Center, ...

Working unconventional hours disrupts the body’s internal clock, which in turn affects the immune system and increases people ...

Ho Chi Minh City's Blood Transfusion and Hematology Hospital is preparing to produce CAR-T cells for blood cancer treatment, ...

Authorities say an inmate at the County Jail broke a window during an outburst that occurred as the jail’s nurse was distributing medications. Hajji McReynolds, 47, was charged with felony criminal ...

Usually affectionate, it was when Bruce Willis started to become indifferent to his family that his wife, Emma, started to ...

The CD20 inhibitor Ocrevus (ocrelizumab) rapidly depletes immune B-cells in people with multiple sclerosis (MS), as expected, but ongoing treatment also leads to changes in immune T-cells, a new study ...

Contributed by Rafi Ahmed; received December 23, 2024; accepted August 2, 2025; reviewed by Carl H. June and Alan J. Korman ...